# Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda

> **NCT02094508** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 173 (actual)

## Conditions studied

- Malaria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02094508
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-07
- **Primary completion:** 2015-12-28
- **Final completion:** 2016-12-14
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02094508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02094508, "Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02094508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*